Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01392989
Recruitment Status : Completed
First Posted : July 13, 2011
Last Update Posted : June 5, 2018
Information provided by (Responsible Party):
Everett Meyer, Stanford University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 7, 2016
  Actual Study Completion Date : March 19, 2017